Octavio Espinoza - Chief Financial Officer at Ligand Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Octavio Espinoza - trading volume in the past year for Ligand Pharmaceuticals Inc

Holdings reported by Octavio Espinoza for Ligand Pharmaceuticals Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 26.4K $3.03M $115.03 Mar 4, 2025 Direct
Employee Stock Option (right to buy) 32.7K Mar 4, 2025 Direct Common Stock
Non-Qualified Stock Option (right to buy) 16.2K May 17, 2024 Direct Common Stock
Incentive Stock Option (right to buy) 0 Aug 28, 2024 Direct Common Stock

Transactions reported by Octavio Espinoza for Ligand Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.